Author

S.-M. Kang

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:host-pathogen & immune response· 3 Organism:mouse· 3 Approach:experimental assay· 2 Research Focus:benchmarking· 1 Approach:biophysical modeling· 1 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

A. Debin· 1 shared A. N. Blackerby· 1 shared C. D. Pack· 1 shared C. N. Wright· 1 shared D. C. Neujahr· 1 shared D. Kim· 1 shared D. P. Jones· 1 shared E. Ko· 1 shared

Activity by Year

2018-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 12 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Debin

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

The defined TLR3 agonist, Nexavant, exhibits anti-cancer efficacy and potentiates anti-PD-1 antibody therapy by enhancing immune cell infiltration.

D. Kim, S.-H. Lee, Y.-H. Choi, S.-M. Kang, M.-G. L. Lee, S.-B. Hong, E. Perouzel, A. Debin

This paper evaluates Nexavant, a TLR3 agonist, showing enhanced anti-cancer effects and synergy with anti-PD-1 therapy through immune cell infiltration.

bioRxiv · Oct 25, 2023Immunology

Influenza virus-like particle-based hybrid vaccine containing RBD induces immunity against influenza and SARS-CoV-2 viruses

R. Bommireddy, S. Stone, N. Bhatnagar, P. Kumari, L. E. Munoz, J. Oh, K.-H. Kim, J. T. Berry, K. Jacobsen, J. Lahcen, S.-H. Naing, A. N. Blackerby, T. V. d. Gaag, C. N. Wright, L. Lai, , P. Selvaraj

This study develops a hybrid vaccine combining influenza VLPs with SARS-CoV-2 RBD and GM-CSF, showing protection against both viruses in mice.

bioRxiv · Feb 1, 2022Immunology

Low-dose cadmium potentiates lung inflammatory response to 2009 pandemic H1N1 influenza virus in mice

J. D. Chandler, X. Hu, E. Ko, S. Park, J. Fernandes, Y.-T. Lee, M. L. Orr, L. Hao, M. R. Smith, D. C. Neujahr, K. Uppal, S.-M. Kang, D. P. Jones, Y.-M. Go

This study shows that low-dose cadmium exposure in mice increases lung inflammation and genetic responses to H1N1 influenza virus infection.

bioRxiv · Nov 15, 2018Pharmacology & Toxicology